The main limitation of non-viral gene transfer methods is their relati
vely low efficiency in vivo. However, a number of approaches can be ta
ken to improve their performances, whether the aim is studying gene fu
nction during development or employing these techniques for gene thera
py. Three non-viral delivery systems that we have been particularly in
volved in in developing are described: the cationic lipid, dioctadecyl
amidoglycylspermine (DOGS), the cationic polymer polyethylenimine (PEI
) and free DNA. The application of each of these methods to different
in vivo situations is presented: the use of DOGS for transfecting embr
yos and the developing mammalian nervous system; the recent applicatio
n of PEI to the nervous system; and how naked DNA can be employed for
transfecting different muscles and brain. The relative efficiencies ar
e compared on the basis of luciferase reporter gene expression assesse
d in each tissue with the most appropriate vector system. Finally, the
perspectives for constructing composite vectors combining safety and
efficiency are considered briefly.